Rockefeller Capital Management’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
Rockefeller Capital Management's ZYME Position: Q3 2026 in Review
Rockefeller Capital Management increased its Zymeworks (ZYME) stake by 3,525% in Q3 2026, buying an estimated $55.7K and bringing the position to 2,211 shares worth $58.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3371.
Rockefeller Capital Management first reported a position in ZYME in Q3 2019 and has held it in 17 quarters since. The position peaked at $87K in Q3 2020. 203 funds tracked by Wall St. Rank hold ZYME as of Q3 2026.
- Rockefeller Capital Management held 2,211 shares of Zymeworks worth $58.6K as of Q3 2026.
- Rockefeller Capital Management bought 2,150 Zymeworks shares in Q3 2026, an estimated $55.7K.
- Zymeworks made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #3371 holding.
- Rockefeller Capital Management first reported a position in Zymeworks in Q3 2019 and has held it in 17 quarters since.
- Rockefeller Capital Management's Zymeworks position peaked at $87K in Q3 2020.
- 203 funds tracked by Wall St. Rank held Zymeworks as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.